325 related articles for article (PubMed ID: 29617457)
21. IMM-H004 prevents toxicity induced by delayed treatment of tPA in a rat model of focal cerebral ischemia involving PKA-and PI3K-dependent Akt activation.
Zuo W; Chen J; Zhang S; Tang J; Liu H; Zhang D; Chen N
Eur J Neurosci; 2014 Jun; 39(12):2107-18. PubMed ID: 24649933
[TBL] [Abstract][Full Text] [Related]
22. Normobaric hyperoxia reduces the neurovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia.
Liu W; Hendren J; Qin XJ; Liu KJ
Stroke; 2009 Jul; 40(7):2526-31. PubMed ID: 19478225
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of the Sur1-Trpm4 channel reduces neuroinflammation and cognitive impairment in subarachnoid hemorrhage.
Tosun C; Kurland DB; Mehta R; Castellani RJ; deJong JL; Kwon MS; Woo SK; Gerzanich V; Simard JM
Stroke; 2013 Dec; 44(12):3522-8. PubMed ID: 24114458
[TBL] [Abstract][Full Text] [Related]
24. The sulfonylurea receptor 1 (Sur1)-transient receptor potential melastatin 4 (Trpm4) channel.
Woo SK; Kwon MS; Ivanov A; Gerzanich V; Simard JM
J Biol Chem; 2013 Feb; 288(5):3655-67. PubMed ID: 23255597
[TBL] [Abstract][Full Text] [Related]
25. YiQiFuMai Lyophilized Injection ameliorates tPA-induced hemorrhagic transformation by inhibiting cytoskeletal rearrangement associated with ROCK1 and NF-κB signaling pathways.
Pan XW; Wang MJ; Gong SS; Sun MH; Wang Y; Zhang YY; Li F; Yu BY; Kou JP
J Ethnopharmacol; 2020 Nov; 262():113161. PubMed ID: 32730882
[TBL] [Abstract][Full Text] [Related]
26. Glibenclamide Directly Prevents Neuroinflammation by Targeting SUR1-TRPM4-Mediated NLRP3 Inflammasome Activation In Microglia.
He Y; Chang Y; Peng Y; Zhu J; Liu K; Chen J; Wu Y; Ji Z; Lin Z; Wang S; Gupta S; Zang N; Pan S; Huang K
Mol Neurobiol; 2022 Oct; 59(10):6590-6607. PubMed ID: 35972671
[TBL] [Abstract][Full Text] [Related]
27. PI3Kγ (Phosphoinositide 3-Kinase-γ) Inhibition Attenuates Tissue-Type Plasminogen Activator-Induced Brain Hemorrhage and Improves Microvascular Patency After Embolic Stroke.
Jin R; Xiao AY; Li J; Wang M; Li G
Hypertension; 2019 Jan; 73(1):206-216. PubMed ID: 30571560
[TBL] [Abstract][Full Text] [Related]
28. Toll-Like Receptor 4 Mediates Hemorrhagic Transformation After Delayed Tissue Plasminogen Activator Administration in In Situ Thromboembolic Stroke.
García-Culebras A; Palma-Tortosa S; Moraga A; García-Yébenes I; Durán-Laforet V; Cuartero MI; de la Parra J; Barrios-Muñoz AL; Díaz-Guzmán J; Pradillo JM; Moro MA; Lizasoain I
Stroke; 2017 Jun; 48(6):1695-1699. PubMed ID: 28428349
[TBL] [Abstract][Full Text] [Related]
29. Melatonin inhibits postischemic matrix metalloproteinase-9 (MMP-9) activation via dual modulation of plasminogen/plasmin system and endogenous MMP inhibitor in mice subjected to transient focal cerebral ischemia.
Tai SH; Chen HY; Lee EJ; Chen TY; Lin HW; Hung YC; Huang SY; Chen YH; Lee WT; Wu TS
J Pineal Res; 2010 Nov; 49(4):332-41. PubMed ID: 20663046
[TBL] [Abstract][Full Text] [Related]
30. Mild to moderate hypothermia prevents microvascular basal lamina antigen loss in experimental focal cerebral ischemia.
Hamann GF; Burggraf D; Martens HK; Liebetrau M; Jäger G; Wunderlich N; DeGeorgia M; Krieger DW
Stroke; 2004 Mar; 35(3):764-9. PubMed ID: 14976330
[TBL] [Abstract][Full Text] [Related]
31. Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats.
Sumii T; Lo EH
Stroke; 2002 Mar; 33(3):831-6. PubMed ID: 11872911
[TBL] [Abstract][Full Text] [Related]
32. Phthalide derivative CD21 attenuates tissue plasminogen activator-induced hemorrhagic transformation in ischemic stroke by enhancing macrophage scavenger receptor 1-mediated DAMP (peroxiredoxin 1) clearance.
Liu DL; Hong Z; Li JY; Yang YX; Chen C; Du JR
J Neuroinflammation; 2021 Jun; 18(1):143. PubMed ID: 34162400
[TBL] [Abstract][Full Text] [Related]
33. A Rho kinase (ROCK) inhibitor, fasudil, prevents matrix metalloproteinase-9-related hemorrhagic transformation in mice treated with tissue plasminogen activator.
Ishiguro M; Kawasaki K; Suzuki Y; Ishizuka F; Mishiro K; Egashira Y; Ikegaki I; Tsuruma K; Shimazawa M; Yoshimura S; Iwama T; Hara H
Neuroscience; 2012 Sep; 220():302-12. PubMed ID: 22710066
[TBL] [Abstract][Full Text] [Related]
34. Silencing of Abcc8 or inhibition of newly upregulated Sur1-Trpm4 reduce inflammation and disease progression in experimental autoimmune encephalomyelitis.
Makar TK; Gerzanich V; Nimmagadda VK; Jain R; Lam K; Mubariz F; Trisler D; Ivanova S; Woo SK; Kwon MS; Bryan J; Bever CT; Simard JM
J Neuroinflammation; 2015 Nov; 12():210. PubMed ID: 26581714
[TBL] [Abstract][Full Text] [Related]
35. Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke.
Ning M; Furie KL; Koroshetz WJ; Lee H; Barron M; Lederer M; Wang X; Zhu M; Sorensen AG; Lo EH; Kelly PJ
Neurology; 2006 May; 66(10):1550-5. PubMed ID: 16717217
[TBL] [Abstract][Full Text] [Related]
36. Role of tissue-type plasminogen activator in ischemic stroke.
Suzuki Y
J Pharmacol Sci; 2010; 113(3):203-7. PubMed ID: 20595786
[TBL] [Abstract][Full Text] [Related]
37. Atorvastatin downregulates tissue plasminogen activator-aggravated genes mediating coagulation and vascular permeability in single cerebral endothelial cells captured by laser microdissection.
Liu XS; Zhang ZG; Zhang L; Morris DC; Kapke A; Lu M; Chopp M
J Cereb Blood Flow Metab; 2006 Jun; 26(6):787-96. PubMed ID: 16177809
[TBL] [Abstract][Full Text] [Related]
38. Aggravation of focal cerebral ischemia by tissue plasminogen activator is reversed by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor but does not depend on endothelial NO synthase.
Kilic E; Kilic U; Matter CM; Lüscher TF; Bassetti CL; Hermann DM
Stroke; 2005 Feb; 36(2):332-6. PubMed ID: 15625301
[TBL] [Abstract][Full Text] [Related]
39. Recombinant ADAMTS13 reduces tissue plasminogen activator-induced hemorrhage after stroke in mice.
Wang L; Fan W; Cai P; Fan M; Zhu X; Dai Y; Sun C; Cheng Y; Zheng P; Zhao BQ
Ann Neurol; 2013 Feb; 73(2):189-98. PubMed ID: 23280993
[TBL] [Abstract][Full Text] [Related]
40. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.
Zhang Y; Wang Y; Zuo Z; Wang Z; Roy J; Hou Q; Tong E; Hoffmann A; Sperberg E; Bredno J; Berr SS; Xie M; Lee K; Wintermark M
J Neurol Sci; 2014 Dec; 347(1-2):148-54. PubMed ID: 25292413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
